Abiomed

Abiomed

World Rank (Aug-2026)
1064
World Rank (Jan-05-2024)
1,064
World Rank (Jul-30-2023)
1,064
Market Cap (Jul-30-2023)
17.181 Billion USD
World Rank (Jan-07-2022)
1,389
Market Cap (Jan-07-2022)
14.526 Billion USD
World Rank (Jan-01-2021)
1,213
Market Cap (Jan-01-2021)
14.651 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 431
Headquarters Country
USA
Top Healthcare Companies in USA
Top Healthcare Companies in S&P 500
CEO
Michael R. Minogue
Employee Count
2,003
Employee Count as of Date
As on 2022
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1,032 Million USD
Annual Operating Income in USD
141 Million USD
Annual Net Income in USD
137 Million USD
Annual Results for Period Ending
For year ending March-2022
Total Assets in USD
1,673 Million USD
Total Liabilities in USD
170 Million USD
Total Equity in USD
1,503 Million USD
Balance Sheet for Period Ending
As of March-2022
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Company Website
ABIOMED INC
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Facebook
Facebook
Company Profile

Abiomed is a medical devices and Healthcare company. It's products are designed to enable the heart to rest by improving blood flow and performing the pumping of the heart. The company efforts on developing ground breaking technologies designed to improve the patient outcomes focused on native heart recovery. The headquarters is in USA.

Johnson & Johnson acquired Abiomed for 16.6 billion USD and acquisition process was completed in Dec-2022.

As of 2022, Abiomed had 2,003 employees.

Abiomed annual revenue generated for period ending Mar-2022 was 1,031million USD.

Abiomed annual net income generated for period ending Mar-2022 was 136 million USD.

Annual Results Summary

ABIOMED - Annual Result Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Mar-20221,031843256136
Mar-2021847685229225
Mar-2020841690249203
Mar-2019769640225259
Mar-2018594495157112
Mar-20174453759052
Balance Sheet Summary

Total Assets as on Mar-2022 was 1,673 Million USD.

Total Liabilities as on Mar-2022 was 170 Million USD.

Total Equity as on Mar-2022 was 1,503 Million USD.

Founded Year
1981

Share